November 28, 2018
Sumitomo Dainippon Pharma said on November 27 that it has reached a settlement with all 16 generic firms over patent infringement lawsuits in the US regarding its antipsychotic agent Latuda (lurasidone). Sumitomo Dainippon filed lawsuits jointly with its US unit...read more